Adding motixafortide to standard stem cell mobilization therapy for autologous hematopoietic stem cell transplantation (ASCT) significantly improved collection success rates vs standard therapy plus a ...
Mike Smith, stem cell laboratory manager, said: "Across the globe, transplant recipients are being given that second chance." ...
A live colony of human induced pluripotent stem cells fills the screen of a microscope. (Allen Institute Photo) Space: The final frontier … for stem cells? Seattle’s Allen Institute for Cell Science ...
This week’s episode of “The Top Line” is the second part of a three-part series exploring the latest advancements in cell and gene therapy manufacturing. In this episode, Fierce Pharma’s Fraiser ...
The world’s only cell therapy collection vehicle opened in San Antonio and recorded its first donation on Monday, Oct. 20, 2025. (BBG Advanced Therapies) SAN ANTONIO – The world’s only cell therapy ...
All cell types found in the body are derived from stem cells. However, genetic mutations can impact the ability of stem cells to develop into fully functional cells. Also, as the body ages, the number ...
The combination therapy is the first FDA approved for the mobilization of hematopoietic stem cells prior to autologous transplantation in patients with multiple myeloma. The FDA approved motixafortide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback